Stockreport

Satsuma Pharmaceuticals to Host Key Opinion Leader Event: STS101 and the Acute Treatment of Migraine

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report
PDF SOUTH SAN FRANCISCO, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, announced tod [Read more]